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Abstract
7KH/RQJ476\QGURPH /476 LVDIDPLOLDO SRWHQWLDOO\IDWDOFDUGLDFDUUK\WKPLD7UDGLWLRQDOO\ LWKDVEHHQGLDJQRVHGE\(&*
Molecular studies have provided evidence that LQTS can be caused by a range of underlying molecular abnormalities. Genetic
research has proven that different forms of LQTS have different genotypic bases. Therefore, it has become possible to diagnose
WKHVSHFLÀFW\SHRIGLVHDVHJHQHWLFDOO\7KLVVWXG\H[DPLQHVWKHDGYDQFHPHQWVPDGHLQWKHSDVWWKLUW\\HDUVLQXQGHUVWDQGLQJ
/476DQGUHVHDUFKUHJDUGLQJWKHXVHRIJHQHWLFWHVWLQJ LQRUGHUWRGHWHUPLQHWKHEHQHÀWVRIJHQHWLFWHVWLQJIRUWKLVGLVHDVH$
survey of original studies which produced the information is presented here, and provides the reader with an understanding of the
PHFKDQLFVRIWKHGLVHDVHDQGKRZWKH\GLIIHULQWKHVHYHUDOJHQHWLFYDULDQWV5HVHDUFKVKRZVWKDWWKHEHQHÀWRIJHQHWLFWHVWLQJ
must be weighed against the personal implications in may have for a particular patient and his or her family.
Introduction

Methods

In the year 1856, the German scientist Freidrich Ludwig
0HLVVQHU GHVFULEHG ZKDW PD\ KDYH EHHQ WKH ÀUVW UHFRUGHG
case of the Long QT syndrome (LQTS). He recorded a case in
which a deaf female student died suddenly during a moment of
emotional stress.There had been two other children in her family who had died previously under similar circumstances. Since
a diagnosis of LQTS requires an electrocardiogram, and at that
time the ECG had not yet been invented, (Rivera-Ruiz, 1927)
it is not known for certain that these cases were an example
of LQTS (Vincent, 2002). Over a hundred years later, a study
was performed on a family of 10 children. Four of the children
had profound deafness and would often faint during moments
of emotional or physical stress (Jervell, Lange-Neilson, 1957).
Later, a similar familial tendency to faint during stress was observed in case studies (Ward, 1964). A prolonged QT interval
was observed in the ECGs of subjects. At that time, two familial
heart diseases known collectively as Long QT Syndrome were
IXOO\GLVFRYHUHGDQGGHÀQHG
The advent of molecular and genetic science has revolutionized the medical world’s approach to this disease, as it has
done for that of many others. Molecular studies have divided
the cases of LQTS, which seemed in the past like one basic
condition, into larger categories differentiated based upon molecular mechanism. Genetic differences were discovered between these types in the lab, and since genetic testing became
available to the public in 2004, 15 categories including over
1500 different mutations have been found to be the underlying
cause of a prolongation of the QT interval. This study focuses on the three categories which make up the overwhelming
majority of cases. In some cases, certain genetic origins and
molecular mechanisms have been linked to certain phenotypic
characteristics, and some believe that genetic diagnosis may
aid in recommendations and treatment for LQTS patients.
This study aims to give a full description of the physiological
and molecular mechanisms of LQTS based upon the latest research, and analyze the contribution of genetic research to the
understanding and treatment of the disease. Most importantly,
the primary objective of this study is to answer the question:
Should genetic testing be universally recommended to LQTS
patients and their relatives?

The Touro library system was an invaluable source of recent,
high-quality academic papers. In addition, the National Institutes
of Health and NCBI provided excellent references to PubMed
articles which provided useful information. The author sought
out independent studies and other primary sources to provide up-to-date reports of developments in the molecular and
genetic understanding of the disease. Studies regarding recent
DWWHPSWV DW JHQHVSHFLÀF WUHDWPHQWV DQG FXUUHQW DFDGHPLF
medical surveys are considered in determining when genetic
testing is indicated.
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Discussion
Physiology of LQTS
The QT interval indicates the length of time from the beginning of the depolarization of the ventricles to the end of their
repolarization. A prolonged QT interval will mean that the
ventricles are taking too long to repolarize. This usually does
not interfere with cardiac function, but occasionally can cause
OLIHWKUHDWHQLQJ YHQWULFXODU ÀEULOODWLRQ7KH PDMRU PHFKDQLVP
RI YHQWULFXODU ÀEULOODWLRQ ZKLFK LV EURXJKW DERXW E\ D SURlonged QT interval is the result of Early Afterdepolarizations
(EADs). The plateau curve caused by the delay in repolarization can cause some of the heart’s cells to begin depolarizing
while others are in the process of repolarizing. This can cause
heterogeneous activity in the heart tissue, especially the ventricles, with some regions contracting and others relaxing. The
UHVXOWLVDTXLYHULQJRUÀEULOODWLQJKHDUWZKLFKFDQQRWSURGXFH
VXIÀFLHQWEORRGRXWSXWDQGTXLFNO\OHDGVWRV\QFRSHDQGGHDWK
(January, et. al. 2000).

Clinical Manifestation
Normally, depolarization and excitation of the cells of the heart
DUH FDXVHG E\ D TXLFN ÁRZ LQZDUGV RI SRVLWLYHO\ FKDUJHG LRQV
These are usually Sodium and Calcium ions. However, the repoODUL]DWLRQRIWKHFHOOVLVQRWWKHUHVXOWRIWKRVHVDPHLRQVÁRZLQJ
back out; it is an outward current of positively charged Potassium
LRQV ZKLFK FDXVHV UHSRODUL]DWLRQ$V WKH 3RWDVVLXP RXWÁRZ LQFUHDVHV LW RYHUWDNHV WKH 6RGLXP LQÁRZ DQG WKH FHOO EHJLQV WR
repolarize. In all forms of LQTS, the symptoms are caused by
a surplus of positive charges remaining within the cell. When
some channels malfunction, the extra positive charge is caused
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by reduced outward Potassium current. When other channels
malfunction, the extra positive charge is caused by increased or
unchecked inward Sodium current. In either case early afterdepolarizations can result, meaning that depolarization may still be
going on after the effects of repolarization have subsided.This can
cause what is called a U wave (Roden, et. al. 1996). This U wave,
however, is not a homogenous contraction of the heart. Some of
the cells will show this depolarization, and others will not. If this
EAD is still going on when the next beat occurs, it can cause the
heart to contract in an uneven way (Antzelevitch, Sicouri, 1994).
This leads to a characteristic ECG graph known as Torsades de
Pointes. This is French for “Twisting of the Points,” and is named
for the peculiar way the wave form seems to twist around the
isoelectric line (El-Sherif, et. al. 1996).
7RUVDGHVGH3RLQWHVLVQRWDEOHWRVXVWDLQDVXIÀFLHQWVWURNH
volume of blood to support brain function. After some time
with this abnormal ECG morphology, the patient will faint. Most
of the time, the heart will overcome the Torsades and regain a
normal heartbeat. At other times, the heart will not be able to
“snap out of it” and the rhythm will deteriorate to ventricular
ÀEULOODWLRQ ZLWKRXW SURYLGLQJ DQ\ PHDQLQJIXO RXWSXW RI EORRG
Unfortunately, this situation leads to death within minutes.
A patient who presents with Torsades is considered a medical
HPHUJHQF\GXHWRWKHULVNRIYHQWULFXODUÀEULOODWLRQZKLFKPD\
result. However, the situation rights itself in the vast majority of
FDVHV7KHUHIRUH'&VKRFNGHÀEULOODWLRQLVQRWXVHGDVDSULmary course of action since it can cause recurrent arrhythmias.
One of the major aspects of treatment is preventing the patient
from returning to a state of Torsades; whatever caused it the
ÀUVWWLPHPLJKWFDXVHLWDJDLQ7KHUHIRUHLWLVXUJHQWWRUHPRYH
or mitigate the effects of any drugs which may have caused the
Torsades. It is also advisable to take measures to suppress EADs,
among other things. Magnesium is effective at suppressing EADs
(Viskin, 1999).
Since the danger resulting from a prolonged QT interval depends not only on the actual length of the interval but also the
way it interacts with the surrounding segments of the ECG wave,
it is important to have a method with which to accurately meaVXUH WKH FOLQLFDO VLJQLÀFDQFH RI DQ\ SDUWLFXODU 47 SURORQJDWLRQ
To this end, the concept of QTc was developed, in which the
actual length of the QT interval is mathematically corrected to
take heart rate into account (Bazett, 1920). Since that time, many
other methods have been proposed, and the medical community
is currently in debate over which is most useful and accurate.

Molecular Mechanisms
To understand the cellular and molecular mechanics of Long
QT Syndrome, we must understand the process of the action potential itself. At rest, nerve cells have a higher level of
positive charge outside the cell than they do inside. When a
nerve cell is stimulated, the chemical or electrical impulse it

receives activates voltage- or ligand-gated Sodium channels.
7KLVFUHDWHVDQLQÁX[RISRVLWLYHFXUUHQW GHSRODUL]DWLRQ $IWHU
DFHUWDLQDPRXQWRISRVLWLYHÁRZLVDGPLWWHGWRWKHFHOOYROWDJHJDWHG3RWDVVLXPFKDQQHOVDUHDFWLYDWHGFUHDWLQJDQRXWÁRZ
of Potassium ions and returning the cell to its resting state with
more positive charge on the outside. Many different types of
channels are involved in these processes. Cardiac muscle cells
are unusual in the sense that they act to carry an action potenWLDO DV HIÀFLHQWO\ DV QHUYRXV WLVVXH FDQ DQG WKHUHIRUH GHSHQG
upon a similar set of ion channels (Sanguinetti, Jurkiewicz, 1990).
We will delve deeper into this process shortly.
Some years ago, a groundbreaking study uncovered information about the process of repolarization in cardiac tissue.
The goal was to understand electrophysiological differences
between different areas of the heart. Microelectrodes were
used to measure delays in repolarization found in certain canine
heart cells, known as M cells. These cells, which had been previously found to show markedly longer repolarization times, are
found in the deep sub-pericardial and mid-myocardial regions.
The researchers measured the durations of their action potentials to have a mean of 358 ms, as opposed to 282 ms or 287 ms
found in other regions of cardiac muscle. Upon further examination of the M cells, it was shown that they show differences
in IK when compared to other cells. IK means Potassium ion
current, which is the current responsible for the repolarization
that ends every action potential.There are two distinct currents
found in cardiac cells, the IKr, or rapid-activating current, and
the IKs, or slow-activating current. These currents are mediated
by two separate transmembrane voltage-gated protein channels.
The M cells have smaller IKs (Slow-acting Potassium current)
than the other cells, while IKr (Rapid-acting Potassium current)
is generally the same. (Of course, the mechanism for the rate
of an action potential has many factors, and depends upon the
LQZDUG UHFWLÀHU ,.  &DOFLXP LRQ LQZDUG FXUUHQW 6RGLXP
Potassium pump inward current, Sodium-Calcium inward current, and others.) (Sanguinetti, Jurkiewicz, 1990). The IKs in the
M cells was measured using a selective IKr blocker, E-4031. The
Potassium current was measured in the cells with E-4031 and
in the cells without E-4031. The difference between the two
measurements was the IK due to IKr, and the common portion
was the IK due to IKs. It was found that the IKr in different cell
types was essentially the same, and reduced IKs current was
responsible for the delayed repolarization in the M cells. It was
discovered in this study that IKr differs from IKs in its kinetics of
activation, more negative threshold for activation, and different
protein structure suggested by its selective blockage by methane sulfonamide class III agents like E-4031. However, studies of
M cells demonstrated that delayed IKs can play a principle role
in delayed repolarization. The researchers predicted that the M
cells may be found to be the culprits of diseases such as LQTS
(Liu, Antzelevitch, 1995).
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Later the same year, it was shown that the plateau portion of
repolarization is accomplished principally by the IKs protein. It
was also discovered that in the heart in general, blocking either
IKr or IKs can prolong duration of the action potential by the
same degree. This means that either protein can be a target for
antiarrhythmic drugs for tachycardia. By the same token, either
protein could also be the culprit of an arrhythmia with extended action potentials, such as LQTS (Zeng, et. al. 1995.) As we
ZLOO VHH VRRQ JHQHWLF VWXGLHV KDYH FRQÀUPHG WKDW /476 FDQ
result from mutations in the genes which code for either of the
proteins, and others as well.

Genetic Variation
It has been known for many years that not all cases of LQTS
have the same symptoms. For example, some cases of LQTS
DUHGDQJHURXVVSHFLÀFDOO\XQGHUVLWXDWLRQVRIHPRWLRQDOVWUHVV
Other cases are set off especially by exercise, whereas some
FDVHV VHHP WR FDXVH V\QFRSH VSHFLÀFDOO\ GXULQJ VZLPPLQJ ,W
was established that in these cases it was not the stress or
exercise of swimming which caused the ill effects, but rather the
actual immersion of the face in cold water (Mayumi, et.al. 1995).
Genetic research has since shown that mutations in several
genes, coding for several proteins, can cause LQTS. Different
types of the disease have been linked to different genes, and
over 1500 different novel mutations have thus far been discovered on 15 different genes which code for 15 different proteins.
One such gene is the KCNQ1 gene. This gene on chromosome
11 codes for the alpha subunit of the voltage-gated Potassium
channel. It has six transmembrane domains. Even though there
is ion pore function for this protein alone, some of the functioning of the channel requires it to be co-assembled with the
beta subunit. This subunit is called KCNE1. The two subunits
together account for the cardiac IKs. Mutations in different segments of this protein channel cause varying degrees and kinds
of diseases. The S4 domain contains a voltage sensor, and lossof function mutations in this area can cause LQTS. In addition,
WKHUHLVDSRUHKHOL[VHOHFWLYLW\ÀOWHUVHJPHQWZKLFKFDQZKHQ
its shape is altered, severely affect the functioning of the IKs
current. In this segment, certain mutations cause more loss of
function than others. For example, an I313K mutation in the seOHFWLYLW\ÀOWHUVHJPHQWFDQFDXVHDOORIWKHV\PSWRPVRI/476
including syncope and risk of death, whereas an I313M mutation
will prolong the QT interval, but the patient will be otherwise
asymptomatic. All KCNQ1 and KCNE1 mutations are included
in the category LQT1 (Ikrar, et. al. 2008).
LQT2 is a result of a loss of function in the HERG channel.
HERG stands for Human Ether a go go related gene, so named
IRU WKH IDFW WKDW D PXWDWLRQ LQ LWV KRPRORJ LQ IUXLW ÁLHV FDXVHV
them to “dance” when exposed to ether. More than 80 mutations
were known in this gene in 2000, and many more are known
today. HERG is a gene located on chromosome 7 that codes for
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the pore-forming subunit for the IKr channel. There are several
mechanisms by which HERG mutations cause reduced IKr. One
of them is that a certain degree of codominance exists in heterozygous individuals with certain mutations. The protein which
comprises the HERG channel is actually a tetrameric structure
formed by the co-assembly of four copies of the HERG gene
product. Depending on how the subunits combine, the mutant
gene products might be excluded from the ion pores, causing
a 50% reduction in pore function. On the other hand, the mutants might be included in some of the complete proteins, causing
more than 50% to be defective. Other mutations in the HERG
gene are truly dominant, and produce channels which activate
at voltages which are more negative than usual. One mutation,
N629D, was found to make the pore channel nonselective and
allow ions other than K+ to pass through. Interestingly, many
mutations in the HERG protein affect not the actual functioning
RIWKHLRQSRUHEXWLWV´WUDIÀFNLQJµLHLWVDELOLW\WREHSURSHUO\
packaged and transported to the plasma membrane. In these
cases, the mutant proteins are marked as abnormal by the cell’s
quality control systems and are kept in the endoplasmic reticulum and degraded. In these scenarios, applying E-4031 to affected
FHOOVZDVVKRZQWRDOORZWUDIÀFNLQJRIWKHSURWHLQVWRWKHSODVPD
membrane, and the drug could later be washed off. Applying this
method in vivo is still an area of study for these particular mutant
IRUPV7KLVLVDIRUPRIJHQHVSHFLÀFWKHUDS\IRU/47$QRWKHU
form may be increasing serum K+ concentration, since HERG
current is highly sensitive to extracellular K+ concentration.
(January, et. al. 2000)
0RUHZRUNZDVGRQHUHFHQWO\RQDWWDFNLQJWKHJHQHVSHFLÀF
WKHUDS\SUREOHPIURPWKHWUDIÀFNLQJDQJOH,WKDVEHHQVKRZQ
that certain mutations cause misfolding of the protein, and this
is what prevents it from leaving the endoplasmic reticulum. This
was discovered by causing chemical unfolding of several different mutant forms and measuring the difference between the
stabilities of each mutant’s folding. It was found that there was
a direct correlation between the conformational stability of the
SURWHLQ DQG LWV GHJUHH RI WUDIÀFNLQJ GHÀFLHQF\ +DUOH\ HW DO
2012).
LQT3 is has a very different molecular basis from that of both
/47 DQG /477KH ÀUVW WZR IRUPV RI /RQJ 47 V\QGURPH
are caused by malfunction of Potassium channels. These chanQHOV IXQFWLRQ WR FUHDWH DQ RXWÁRZ RI SRVLWLYH FXUUHQW GXULQJ
repolarization of the heart’s muscle cells. These mutations are
examples of what is known as “loss of function” mutations. In
other words, the protein coded for by the gene does not work
as well with the mutation as it does in the wild type. LQT3,
however, is a “gain of function” mutation. It causes the Sodium
channel pores to become more effective than in the wild type.
This means that the depolarization process lasts longer, thereby
slowing repolarization and extending the QT interval (Mazzanti,
et. al. 2016).

Should Genetic Testing be Recommended for Long QT Syndrome Patients

*HQH6SHFLÀF5HFRPPHQGDWLRQVDQG7KHUDSLHV
Phenotypic differences have been found between LQT1 and
LQT2. Heterogeneity has been noticed among LQTS patients
regarding the effect that exercise has in precipitating Torsades
GH 3RLQWHV DQG YHQWULFXODU ÀEULOODWLRQ ,W ZDV GLVFRYHUHG WKDW
patients matched for age and gender showed differing QT adaptation patterns during exercise. Patients with LQT1 showed
a steady QTc prolongation, even at higher heart rates. Since
each heart beat occurs at a faster rate, and the QT prolongation remains the same, it is more likely that the repolarization
process will interfere with the following QRS complex, bringing
DERXW7RUVDGHV GH 3RLQWHV DQG YHQWULFXODU ÀEULOODWLRQ FDXVLQJ
syncope or death. In LQT2, however, the QT interval prolongation is actually reduced as the heart rate increases, meaning
that the QT interval occupies the same proportion of the total
ECG sequence that it does at lower heart rates, such as during
rest. Therefore there is no greater risk of syncope in LQT2
during exercise than at any other time. This is consistent with
the molecular and genotypic understanding of the differences
between these two disease types. Exercise creates an increase
in sympathetic activity, i.e. the heart is being driven not only
by its internal pacemaker, but also by hormonal and systemic
nervous impulses and stimulants, such as epinephrine and other
adrenergic agents. In this situation, the predominant current for
the increase in the rate of repolarization has been proven to be
the IKs current, precisely that one which is affected by LQT1.
Therefore, it is understandable that LQT1 patients will be more
susceptible to syncope brought on by exercise-related stress.
These differences are generalizations; actual recommendations
to patients still must be based upon observation and testing
under different types of stress (Sy, et. al. 2010).
In addition, many symptoms have been found to be associated with different forms of LQTS. As stated, LQT1 is associated
with syncope brought on by exercise, with swimming being a
particular stimulus in certain cases. LQT2 is associated with
cardiac events connected with mental stress such as fear or
anger. LQT2 patients also faint when they hear sudden noises
such as alarm clocks and phones. LQT3 seems to be associated
with attacks which come while a person is resting or sleeping.
Knowledge of the genetic basis of the disease can thus be helpful
in advising the patient which activities to avoid. However, even
WKRXJK VWDWLVWLFDOO\ WKHUH LV D VLJQLÀFDQW DVVRFLDWLRQ RI WKHVH
properties with these forms of the disease, a genetic diagnosis
LVE\QRPHDQVFRQFOXVLYHRIDVSHFLÀFH[SUHVVLRQ$PRQJWKH
YDULDWLRQVGLVFRYHUHGWKXVIDUPRVWGRQRWH[DFWO\ÀWWKH
general trend. Therefore, although genetic testing can be helpful
in planning an avoidance or treatment plan, clinical manifestation
is the ultimate deciding factor (Mangset, Hoffman, 2014).
6HYHUDO JHQHVSHFLÀF WKHUDSLHV KDYH EHHQ SURSRVHG IRU
LQTS. Beta Blockers are effective for LQT1 and LQT2, whereas
they can have negative effects in the case of LQT3. Potassium

supplements also are suggested for LQT2, since an elevated
blood potassium level has been shown to enhance the activity of
the HERG channels. Mexiletine, a methane sulfonamide Sodium
channel blocker, may be effective for LQT3, as described before.
Although some of these have shown promise, comprehensive
DQGFOHDUSURRIRIWKHLUHIÀFDF\DQGVDIHW\KDVQRW\HWEHHQHVtablished (Viskin, 1999.) Recent studies have shown Mexiletine
to be effective at reducing the QTc of more than two thirds of
patients with LQT3. These studies had certain limitations, howHYHU DQG ZHUH QRW VXIÀFLHQW EDVLV IRU ZLGHVSUHDG XVH RI WKLV
JHQHVSHFLÀFWKHUDS\ 0D]]DQWLHWDO 

Implications of Genetic Testing
Since 2004, genetic testing has been made available on symptomatic people to discover what the genetic source of their
syncopal episodes may be. However, in many cases there is a
dilemma for the patient. Most cases of LQTS do not require
genetic testing for diagnoses, and if pathology is suspected in a
newborn based on heredity, risk of serious effects can usually be
effectively determined by ECG. In addition, even if the genetic
testing comes up clear, preventive measures will still be taken
for anyone whose QTc is over the limit of .45 ms. Therefore,
WKH SULPDU\ MXVWLÀFDWLRQ IRU JHQHWLF WHVWLQJ LV QRW LGHQWLÀFDWLRQ EXW UDWKHU WKH SRVVLELOLW\ WKDW JHQHVSHFLÀF WKHUDS\ ZLOO
EH DYDLODEOH$V H[SODLQHG PRVW JHQHVSHFLÀF WKHUDSLHV ZKLFK
require a genotypic diagnosis are still not available to the public.
Those therapies and recommendations which are available can
be safely used without genetic testing. This creates a dilemma
for many patients and their relatives. On the one hand, there
is the patient’s right to know. A clear, empirical knowledge of
the source of their disease helps some patients adjust and cope
psychologically. On the other hand, who would want to know
for certain that they carry a gene which may or may not have
deleterious effects on their children? Since there are effective
VFUHHQLQJ PHWKRGV DQG WKLV NQRZOHGJH FDQ EH D VLJQLÀFDQW
source of fear and anxiety as well as causing moral dilemmas,
many people are uncomfortable going for testing. Sensitivity to
this discomfort has been termed by some as “the patient’s right
not to know.” This consideration is rarely addressed by health
care providers, and the National Society of Genetic Counselors
is making an effort to educate providers about the psychological
impact of genetic testing (Mangsett, Hoffman, 2014).
A longitudinal study was done to observe the long-term effects of congenital LQTS. Individuals from 328 families with multiple cases of LQTS were observed over the course of several
years. The probands had usually fainted at some time during
their childhood years, with an episode of fainting or death occurring in 50% of them by age 12. The majority were women,
showing that the effects of the gene are more serious in females.
The yearly rate of fainting spells till age 50 was 5.0% per year for
those enrolled in the study, and the rate of death was .9%. This
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was higher not only than the rates in unaffected family members,
but also higher than the rates in affected family members. This
shows that LQTS genes can have a variable level of expression
even among affected people (Moss, et. al. 1996). Since the disease can have varying levels of effect even among those who are
stricken by it, it may be true that testing of all family members
can help in discovering mildly affected people.
More recently, however, a survey was taken to determine the
effects of genetic abnormalities on people who were otherwise
clinically normal in terms of ECG and symptoms. Interestingly,
no ill effects were found to be associated with genetic defects
alone, even in situations where those same genetic defects proGXFHG VLJQLÀFDQW GLVHDVH LQ RWKHU SDWLHQWV 6RPH VXJJHVW WKDW
this might be affected by the fact that genetically positive patients tend to take care to avoid activities which bring on syncopal episodes.This information was not part of the study however, and it is therefore unclear whether clinically normal but
genetically abnormal individuals need to take any action at all
to protect themselves from syncope or death (Lampert, 2015).
One other argument has been made in favor of genetic testing
of family members of affected individuals. Some drugs which are
administered by psychiatrists to relieve psychological symptoms
either function directly through changing the electrophysiological workings of the heart, or have side effects which can affect
or alter the action potential of the heart cells. It is suspected
that an increased rate of sudden death among psychiatric patients may be caused by underlying QT interval abnormalities
which may, when augmented by the effects of the drugs, come to
have deadly effects upon the heart’s rhythm (Sayako, et.al. 2014.)
However, the effects were only observed in a small percentage
of the psychiatric population.
&HUWDLQVSHFLÀFPXWDWLRQVKDYHEHHQLGHQWLÀHGDVFRQFOXVLYHly pathogenic. Individuals who carry these variants are advised
to take beta blockers as a prophylactic measure. Although these
DUHRIÀFLDOUHFRPPHQGDWLRQVGXHWRDQDEXQGDQFHRIFDXWLRQ
WKHUHLVVWLOOQRHYLGHQFHWKDWWKHVHPXWDWLRQVSRVHDVLJQLÀFDQW
risk in unaffected people, and the testing of relatives is not universally required (Vincent, 2001).

Conclusions
The Long QT Syndrome is a great example of how a little information can be a dangerous thing. This is an area in which there
has been a recent surge in pure information: exact mutation types,
statistics, symptoms, etc. However, the tying together and understanding of this information is lagging far behind its production,
and that which exists is ambivalent and confusing. Since people
rely on their healthcare providers not only for information, but
DOVRIRUFRQÀGHQFHDQGUHDVVXUDQFHLWFDQEHGLIÀFXOWIRUWKHSURvider to respond appropriately to questions about this disease.
One patient commented that he gets different recommendations
from the same doctor on different occasions. In these situations
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WKHGRFWRUPXVWWU\WRFRQYH\FRQÀGHQFHWRWKHSDWLHQWZKLOH
KRQHVWO\DGPLWWLQJWKDWKHRUVKHGRHVQRWNQRZWKHIXOOVLJQLÀcance of genetic results, and possibly nobody in the world knows
(Mangsett, Hoffman, 2014).
*HQHWLFWHVWLQJLVGHÀQLWHO\DSRZHUIXOWRROLQWKHXQGHUVWDQGing of LQTS. However, both methods of interpreting the genetic
GDWD DQG WKH WUHDWPHQWV WKDW PLJKW EH WDLORUHG WR WKH VSHFLÀF
types have not yet been developed in a way which provides inVWLWXWLRQDOO\UHFRJQL]HGQHFHVVDU\PHGLFDOEHQHÀW,QDGGLWLRQLQ
PRVWFDVHVRQO\PLQRUEHQHÀWVKDYHEHHQVKRZQWRFRPHIURP
WHVWLQJXQDIIHFWHGUHODWLYHVIRULGHQWLÀFDWLRQSXUSRVHV7KLVPDNHV
LWGLIÀFXOWWRDUJXHWKDWDOOSDWLHQWVDQGUHODWLYHVVKRXOGXQLYHUVDOO\
submit to genetic testing, since research has observed emotionDODQGHWKLFDOGLIÀFXOWLHVZKLFKFDQDULVHIURPWKHWHVWLQJ LWVHOI
+RZHYHU D VSHFLÀF JHQHWLF GLDJQRVLV FDQ LQÁXHQFH WKH UHFRPmendations and, to some degree, the treatment that a patient will
be provided with. In addition, since treatment is recommended
for some variants even in the absence of ECG symptoms, relatives
of individuals with those variants have more reason to submit
for genetic testing. A physician and genetic counselor should
WKHUHIRUHGLVFXVVWKHEHQHÀWVDVZHOODVWKHSLWIDOOVRIWHVWLQJZLWK
the patient or relative, and the patient or relative should decide
whether or not to submit to testing. In the coming years, the apSURYDORIGHYHORSLQJJHQHVSHFLÀFWUHDWPHQWVPD\PDNHJHQHWLF
testing more important for affected individuals.
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